News headlines about Inovalon Holdings (NASDAQ:INOV) have been trending somewhat positive on Saturday, Accern Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Inovalon Holdings earned a daily sentiment score of 0.16 on Accern’s scale. Accern also gave news stories about the technology company an impact score of 47.7556703133338 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Here are some of the media headlines that may have effected Accern’s analysis:

Shares of Inovalon Holdings (NASDAQ INOV) traded down 0.38% during trading on Friday, reaching $13.05. The company had a trading volume of 535,284 shares. The firm has a market capitalization of $1.90 billion, a P/E ratio of 109.66 and a beta of 1.19. The company has a 50 day moving average of $13.09 and a 200-day moving average of $12.59. Inovalon Holdings has a 52-week low of $8.60 and a 52-week high of $16.64.

Inovalon Holdings (NASDAQ:INOV) last released its quarterly earnings data on Wednesday, August 2nd. The technology company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.01. The business had revenue of $110.60 million during the quarter, compared to the consensus estimate of $108.73 million. Inovalon Holdings had a return on equity of 5.17% and a net margin of 4.13%. The firm’s revenue was down 10.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.14 earnings per share. Equities analysts expect that Inovalon Holdings will post $0.31 earnings per share for the current year.

A number of research firms recently issued reports on INOV. Zacks Investment Research raised Inovalon Holdings from a “hold” rating to a “buy” rating and set a $15.00 target price on the stock in a report on Tuesday, May 9th. Robert W. Baird reaffirmed a “neutral” rating and set a $12.00 target price (up from $11.00) on shares of Inovalon Holdings in a report on Friday, June 16th. Finally, BidaskClub raised Inovalon Holdings from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 10th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $15.17.

TRADEMARK VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Inovalon Holdings (INOV) Share Price” was first published by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/12/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-inovalon-holdings-inov-share-price.html.

In related news, insider Shauna L. Vernal sold 19,332 shares of the company’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $13.60, for a total value of $262,915.20. Following the completion of the sale, the insider now owns 66,261 shares in the company, valued at $901,149.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 48.28% of the company’s stock.

Inovalon Holdings Company Profile

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Insider Buying and Selling by Quarter for Inovalon Holdings (NASDAQ:INOV)

Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.